» Articles » PMID: 15945064

Learning and Memory After Neonatal Exposure to 3,4-methylenedioxymethamphetamine (ecstasy) in Rats: Interaction with Exposure in Adulthood

Overview
Journal Synapse
Specialty Neurology
Date 2005 Jun 10
PMID 15945064
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

This study determined whether developmental and adult 3,4-methylenedioxymethamphetamine (MDMA) exposures in rats have interactive effects on body temperature, learning, other behaviors, and monoamine concentrations in the hippocampus, prefrontal cortex, and striatum. Learning was assessed in the Cincinnati water maze (CWM), Morris water maze (MWM), and novel object recognition (NOR). On acquisition trials in the MWM, significant differences from developmental MDMA exposure were found on latency, cumulative distance, path length, and angle of first bearing to the goal, but the early and adult MDMA exposure group performed no worse than the developmental-only MDMA group. In the reversal trials, however, an interaction was seen: latency to the goal, cumulative distance, and angle of first bearing were increased in animals treated both developmentally and in adulthood with MDMA compared with those treated only developmentally. Other tests (elevated zero maze, CWM, NOR, and open-field activity) did not show an interaction, nor did hippocampal concentrations of serotonin or dopamine. However, several behavioral tests showed neonatal MDMA effects, including increased errors in the CWM, reduced time spent with a new object in the NOR test, and reduced locomotor activity in the open-field. By contrast, adult MDMA decreased the number of entries into open quadrants of the elevated zero maze. Litter effects were controlled by treating litter as the experimental unit and using mixed models repeated measures analyses. Correlational analyses suggested that the MWM reversal interaction involves multiple monoamine changes. The results indicate that developmental MDMA exposure can interact with adult exposure to interfere with some aspects of learning.

Citing Articles

A Systematic Review of the MDMA Model to Address Social Impairment in Autism.

Chaliha D, Mamo J, Albrecht M, Lam V, Takechi R, Vaccarezza M Curr Neuropharmacol. 2021; 19(7):1101-1154.

PMID: 33388021 PMC: 8686313. DOI: 10.2174/1570159X19666210101130258.


Cognitive Effects of MDMA in Laboratory Animals: A Systematic Review Focusing on Dose.

Pantoni M, Anagnostaras S Pharmacol Rev. 2019; 71(3):413-449.

PMID: 31249067 PMC: 6607799. DOI: 10.1124/pr.118.017087.


Cincinnati water maze: A review of the development, methods, and evidence as a test of egocentric learning and memory.

Vorhees C, Williams M Neurotoxicol Teratol. 2016; 57:1-19.

PMID: 27545092 PMC: 5056837. DOI: 10.1016/j.ntt.2016.08.002.


Memory Systems and the Addicted Brain.

Goodman J, Packard M Front Psychiatry. 2016; 7:24.

PMID: 26941660 PMC: 4766276. DOI: 10.3389/fpsyt.2016.00024.


Neuronal reorganization in adult rats neonatally exposed to (±)-3,4-methylenedioxymethamphetamine.

Williams M, Skelton M, Longacre I, Huggins K, Maple A, Vorhees C Toxicol Rep. 2014; 1:699-706.

PMID: 25419515 PMC: 4235131. DOI: 10.1016/j.toxrep.2014.08.018.


References
1.
Williams M, Morford L, Wood S, Rock S, McCrea A, Fukumura M . Developmental 3,4-methylenedioxymethamphetamine (MDMA) impairs sequential and spatial but not cued learning independent of growth, litter effects or injection stress. Brain Res. 2003; 968(1):89-101. DOI: 10.1016/s0006-8993(02)04278-6. View

2.
Cole J, Sumnall H . The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA). Neurosci Biobehav Rev. 2003; 27(3):199-217. DOI: 10.1016/s0149-7634(03)00031-9. View

3.
Sprague J, Preston A, Leifheit M, Woodside B . Hippocampal serotonergic damage induced by MDMA (ecstasy): effects on spatial learning. Physiol Behav. 2003; 79(2):281-7. DOI: 10.1016/s0031-9384(03)00092-1. View

4.
Williams M, Moran M, Vorhees C . Refining the critical period for methamphetamine-induced spatial deficits in the Morris water maze. Psychopharmacology (Berl). 2003; 168(3):329-38. DOI: 10.1007/s00213-003-1433-y. View

5.
Green A, Mechan A, Elliott J, OShea E, Colado M . The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev. 2003; 55(3):463-508. DOI: 10.1124/pr.55.3.3. View